-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GRS in Hypertension
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GRS in Hypertension Drug Details: Small molecule is under development for the treatment of stable...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GRS in Stable Angina
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GRS in Stable Angina Drug Details: Small molecule is under development for the treatment of...
-
Product Insights
New![]()
Portable Oxygen Concentrators Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Portable Oxygen Concentrators Pipeline Market Report Overview A Portable Oxygen Concentrator provides a continuous flow of oxygen by separating oxygen from room air and further compressing it followed by its filtration with the help of a molecular sieve. The Portable Oxygen Concentrators pipeline market research report provides comprehensive information about the Portable Oxygen Concentrators pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Belapectin in Plaque Psoriasis (Psoriasis Vulgaris)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Belapectin in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: Belapectin (GR-MD-02) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Golexanolone in Hepatic Encephalopathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Golexanolone in Hepatic Encephalopathy Drug Details: Golexanolone (GR-3027) (CVXL-0060) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Prostate Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Prostate Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drug Details: Dexamethasone sodium phosphate (AVM-0703)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Colon Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Colon Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Gastric Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Non-Small Cell Lung Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Squamous Cell Carcinoma Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Esophageal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Esophageal Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Metastatic Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Metastatic Ovarian Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Myxoid Liposarcoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Myxoid Liposarcoma Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Metastatic Breast Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Metastatic Breast Cancer Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Glioblastoma Multiforme (GBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Glioblastoma Multiforme (GBM) Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Burkitt Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Burkitt Lymphoma Drug Details: Dexamethasone sodium phosphate (AVM-0703) is under development...
-
Product Insights
New![]()
Net Present Value Model: Corcept Therapeutics Inc’s Relacorilant
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Corcept Therapeutics Inc's Relacorilant Drug Details: Relacorilant (CORT-125134) is under development for the treatment of endogenous Cushing's syndrome, advanced/metastatic solid tumors such as platinum-resistant...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drug Details: Dexamethasone...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dexamethasone Sodium Phosphate in Primary Mediastinal B-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dexamethasone Sodium Phosphate in Primary Mediastinal B-Cell Lymphoma Drug Details: Dexamethasone sodium phosphate (AVM-0703) is...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.